Kolexia
Merlin Jean-Louis Pharmacien
Merlin Jean-Louis
Pharmacien
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
162 Activités
340 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs colorectales Métastase tumorale Adénocarcinome Carcinomes Mélanome Métastase lymphatique Tumeurs du poumon Tumeurs de la tête et du cou

Collaborateurs

Voir plus
Harlé Alexandre
Harlé Alexandre
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Leroux-Broussier Agnes
Leroux-Broussier Agnes
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Gilson Pauline
Gilson Pauline
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Laurent-Puig Pierre
Laurent-Puig Pierre
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Novartis
27 collaboration(s)
Dernière en 2023
AstraZeneca
14 collaboration(s)
Dernière en 2022
MSD
5 collaboration(s)
Dernière en 2022
Pierre Fabre
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PERCIMEL: Personalized Circulating DNA Follow-up in Melanoma
Essai Clinique (Institut de cancérologie de Lorraine)   04 mars 2024
EFACog: Evaluation of the Feasibility of Personalized and Preventive Support for COGnitive Complaints, by a Paramedical Caregiver in Women Suffering From Non-Metastatic Breast Cancer, Requiring Chemotherapy (EFACog).
Essai Clinique (Institut de cancérologie de Lorraine)   04 mars 2024
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
Clinical and experimental medicine   17 janvier 2024
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS).
Biomedicines   28 novembre 2023
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.
Scientific reports   31 octobre 2023
Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
Cancers   27 octobre 2023
160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
Molecular Analysis for Precision Oncology Congress 2023 4-6 October 2023   01 octobre 2023
2331P Interest of next generation sequencing (NGS) for integrated molecular diagnosis of HER2-low breast cancer
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
ESMO open   14 septembre 2023